Evidence map›Paper›PMID 31433205›Full record

ArticleJournal of child and adolescent psychopharmacology2019

Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada.

Jean Lachaine, Leila Ben Amor, Tamara Pringsheim, James Burns, Judy van Stralen

Open access · hybridAbstract read
In one paragraph

Article in Journal of child and adolescent psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Jean LachaineFaculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada.
Leila Ben AmorDepartment of Psychiatry, University of Montreal, Montreal, Quebec, Canada.
Tamara PringsheimDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
James BurnsShire, a Takeda company, Toronto, Ontario, Canada.
Judy van StralenCenter for Pediatric Excellence, Ottawa, Ontario, Canada.
Université de Montréal · CAQueen's University · CATakeda (Canada) · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health Care CostsOff-Label UseAdolescentAdrenergic alpha-2 Receptor AgonistsAntipsychotic AgentsAttention Deficit Disorder with HyperactivityChildDelayed-Action PreparationsDrug CostsFemaleGuanfacineHumansMalePatient Acceptance of Health CareQuebecRetrospective StudiesAdrenergic alpha-2 Receptor AgonistsAntipsychotic AgentsDelayed-Action PreparationsGuanfacineRisperidonemetabolic syndromerisperidonesecond-line ADHD therapy

Identifiers

PMID31433205
PMCPMC6885769
OpenAlexW2969521336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.